Merck (MRK) Investor presentation summary

Strategic direction and ambition

• Aims to create value and growth by leveraging expertise in biology, chemistry, and physics, integrated with data and AI.

• Focuses on delivering sustainable value for customers, patients, shareholders, employees, and society.

• Positioned to capture growth from converging scientific disciplines and AI-driven industry transformation.

• Emphasizes adaptability to changing customer and patient needs, with value creation moving downstream as AI accelerates innovation.

Competitive positioning and capabilities

• Operates across the entire value chain of life science-related industries, from lab to commercialization.

• Holds strong competitive positions in high-growth markets, supported by multidisciplinary scientific expertise.

• Differentiates through integrated, end-to-end offerings and platformed capabilities.

• Ongoing portfolio evaluation ensures focus on attractive markets and integrated solutions.

Growth strategy and portfolio development

• Pursues four streams: focus on high-growth value drivers, shift toward integrated workflow solutions, leverage platformed capabilities, and scale innovation via M&A and in-licensing.

• Invests in products and businesses with the highest value and market attractiveness.

• M&A and external innovation are key levers for strengthening the portfolio and building a risk-balanced pharma pipeline.

• Financial criteria for investments include IRR above WACC, EPS pre accretive, and maintaining a strong investment grade rating.